Serveur d'exploration H2N2 - Checkpoint (Istex)

Index « Teeft.i » - entrée « Infectivity »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Infectives < Infectivity < Infectivity assays  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 47.
[0-20] [0 - 20][0 - 47][20-40]
Ident.Authors (with country if any)Title
000088 (2012) R. S. Mcdonald [États-Unis] ; A. R. Sambol [États-Unis] ; B. K. Heimbuch [États-Unis] ; T. L. Brown [États-Unis] ; S. H. Hinrichs [États-Unis] ; J. D. Wander [États-Unis]Proportional mouse model for aerosol infection by influenza
000197 (2010) Brian H. Bossak ; Mark R. WelfordSpatio‐Temporal Attributes of Pandemic and Epidemic Diseases
000554 (2004) Hiroshi Kido [Japon] ; Yuushi Okumura [Japon] ; Hiroshi Yamada [Japon] ; Dai Mizuno [Japon] ; Youichirou Higashi [Japon] ; Mihiro Yano [Japon]Secretory leukoprotease inhibitor and pulmonary surfactant serve as principal defenses against influenza A virus infection in the airway and chemical agents up-regulating their levels may have therapeutic potential
000710 (2001) A. C. M. Boon [Royaume-Uni, Pays-Bas] ; A. M. F. French [Royaume-Uni] ; D. M. Fleming [Royaume-Uni] ; M. C. Zambon [Royaume-Uni]Detection of influenza a subtypes in community‐based surveillance
000711 (2001) Alexander C. Schmidt [États-Unis] ; Robert B. Couch [États-Unis] ; George J. Galasso [États-Unis] ; Frederick G. Hayden [États-Unis] ; John Mills [Australie] ; Brian R. Murphy [États-Unis] ; Robert M. Chanock [États-Unis]Current research on respiratory viral infections: Third International Symposium
000740 (2000) M. J. Edwards [Royaume-Uni] ; N. J. Dimmock [Royaume-Uni]Two Influenza A Virus-Specific Fabs Neutralize by Inhibiting Virus Attachment to Target Cells, While Neutralization by Their IgGs Is Complex and Occurs Simultaneously through Fusion Inhibition and Attachment Inhibition
000766 (2000) Robert W. Sidwell [États-Unis] ; Donald F. Smee [États-Unis]In vitro and in vivo assay systems for study of influenza virus inhibitors
000808 (1999) Hiroshi Kido [Japon] ; Yoshihito Beppu [Japon] ; Yasuhiro Imamura [Japon] ; Ye Chen [Japon] ; Meiko Murakami [Japon] ; Kumiko Oba [Japon] ; Takae Towatari [Japon]The human mucus protease inhibitor and its mutants are novel defensive compounds against infection with influenza A and Sendai viruses
000816 (1999) David A. Steinhauer [Royaume-Uni]Role of Hemagglutinin Cleavage for the Pathogenicity of Influenza Virus
000897 (1998) K. A. Staschke [États-Unis] ; S. D. Hatch [États-Unis] ; J. C. Tang [États-Unis] ; W. J. Hornback [États-Unis] ; J. E. Munroe [États-Unis] ; J. M. Colacino [États-Unis] ; M. A. Muesing [États-Unis]Inhibition of Influenza Virus Hemagglutinin-Mediated Membrane Fusion by a Compound Related to Podocarpic Acid
000898 (1998) Julia Serkedjieva [Bulgarie] ; Alan J. Hay [Royaume-Uni]In vitro anti-influenza virus activity of a plant preparation from Geranium sanguineum L.
000963 (1997) Hong Jin [États-Unis] ; George P. Leser [États-Unis] ; Jie Zhang [États-Unis] ; Robert A. Lamb [États-Unis]Influenza virus hemagglutinin and neuraminidase cytoplasmic tails control particle shape
000A86 (1995) Raphael Levi [Israël] ; Talia Beeor-Tzahar [Israël] ; Ruth Arnon [Israël]Microculture virus titration — a simple colourimetric assay for influenza virus titration
000C58 (1993) 190 Inhibition of influenza virus reproduction by combined preparations of medicinal plants
000C59 (1993) 189 Selective inhibition of myxovirus replication by a novel series of cholesterol-naphthalenesulfonic acid hybrid molecules
000C60 (1993) Viral genetics
000E16 (1990) L. A. White [États-Unis] ; C. Y. Freeman [États-Unis] ; H. E. Hall [États-Unis] ; B. D. Forrester [États-Unis]Inactivation and stability of viral diagnostic reagents treated by gamma radiation
000F09 (1989) B. Fiszon [France] ; C. Hannoun [France] ; A. Garcia-Sastre [Espagne] ; E. Villar [Espagne] ; J. A. Cabezas [Espagne]Comparison of biological and physical properties of human and animal A(H1N1) influenza viruses
000F38 (1988) A. N. Slepushkin [Russie] ; P. A. Patriarca [États-Unis] ; N. P. Obrosova-Serova [Russie] ; M. W. Harmon [États-Unis] ; L. N. Kupryashina [Russie] ; S. G. Cheshik [Russie] ; R. B. Vartanyan [Russie] ; G. I. Alexandrova [Russie] ; F. I. Polezhaev [Russie] ; N. I. Lonskaya [Russie] ; B. V. Yagodovskii [Russie] ; A. P. Kendal [États-Unis] ; V. M. Zhdanov [Russie]Class-specific antibody responses in school children vaccinated with an A/Brazil/11/78 (H1N1)-like recombinant influenza virus prepared from the A/Leningrad/134/57 paediatric cold-adapted donor strain
000F69 (1988) Cumulative subject index volumes 162–167
000F77 (1988) Robert F. Betts [États-Unis] ; R. Gordon Douglas ; Hunien F. Maassab Jr. ; Dan C. Deborde ; Mary Lou Clements [États-Unis] ; Brian R. MurphyAnalysis of virus and host factors in a study of A/Peking/2/79 (H3N2) cold‐adapted vaccine recombinant in which vaccine‐associated illness occurred in normal volunteers

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Istex/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Teeft.i -k "Infectivity" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Teeft.i  \
                -Sk "Infectivity" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    Istex
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Teeft.i
   |clé=    Infectivity
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021